AVA Member Updates

The AVA welcomes Dr David Andrews in his new role as CEO.

The voices of AVA members have been heard: TGA has made an interim decision to keep injectable meloxicam as an S4.

An update on how veterinarians from flood-affected regions have been coping in the current crisis.

Until mid-2021, omeprazole for equines was only available in paste formulations. The new technology of Equestra sees a highly palatable, enteric coated omeprazole product in a granule formulation bringing a new level of convenience to the required daily dosing regimen.

Member feedback is sought on the use of primates and other animals in medical research in NSW.

The AVA is seeking nominations for its Board. Can you join a team of leaders and help to steer the profession in the right direction?

It feels like a long time has passed since I managed to take some brief leave over Christmas and New Year. It was nice and refreshing to spend time with my family and take a break from work and AVA on a short trip to Margaret River.

Find out how you can better support your liver patients while keeping dosing effortless for clients with Blackmore's PAW Hepatoadvanced, the newest liver support product to hit the veterinary market.

The Parliamentary Inquiry into Animal Welfare Policy in NSW is investigating and reporting on NSW animal welfare policy, regulatory and legislative frameworks including reviewing at the draft Animal Welfare Bill.

Central Coast veterinarians are advised to ensure pet rabbits are vaccinated prior to 1 March 2022 due to the Wild Rabbit RHDV-K5 Control Program.